InvestorsObserver
×
News Home

Should You Buy Cronos Group Inc (CRON) Stock After it Has Risen 0.56% in a Week?

Monday, October 18, 2021 02:33 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Cronos Group Inc (CRON) Stock After it Has Risen 0.56% in a Week?

The market has been down on Cronos Group Inc (CRON) stock recently. CRON gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Cronos Group Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CRON!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CRON Stock Today?

Cronos Group Inc (CRON) stock is trading at $5.40 as of 2:22 PM on Monday, Oct 18, a drop of -$0.09, or -1.55% from the previous closing price of $5.48. The stock has traded between $5.38 and $5.51 so far today. Volume today is less active than usual. So far 1,056,087 shares have traded compared to average volume of 1,735,388 shares.

More About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann. Click Here to get the full Stock Report for Cronos Group Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App